Premium
Biological Activity of Cannabichromene, its Homologs and Isomers
Author(s) -
TURNER CARLTON E.,
ELSOHLY MAHMOUD A.
Publication year - 1981
Publication title -
the journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.92
H-Index - 116
eISSN - 1552-4604
pISSN - 0091-2700
DOI - 10.1002/j.1552-4604.1981.tb02606.x
Subject(s) - antibacterial activity , cannabinoid , dermatophyte , biological activity , chemistry , antifungal , pharmacology , phenylbutazone , bacteria , dermatomycosis , drug , microbiology and biotechnology , biology , biochemistry , in vitro , genetics , receptor
Cannabichromene (CBC) is one of four major cannabinoids in Cannabis sativa L. and is the second most abundant cannabinoid in drug‐type cannabis. Cannabichromene and some of its homologs, analogs, and isomers were evaluated for antiinflammatory, antibacterial, and antifungal activity. Antiinflammatory activity was evaluated by the carrageenan‐induced rat paw edema and the erythrocyte membrane stabilization method. In both tests, CBC was superior to phenylbutazone. Antibacterial activity of CBC and its isomers and homologs was evaluated using gram‐positive, gram‐negative, and acid‐fast bacteria. Antifungal activity was evaluated using yeastlike and filamentous fungi and a dermatophyte. Antibacterial activity was strong, and the antifungal activity was mild to moderate.